Latest period
$116B
YoY change
+9.6%
5Y CAGR
+11.3%
Peak year (FY2025)
$114B
Latest annual
$114B
Total Assets history chart for AstraZeneca (AZN) from 2016 to 2025
Latest: $114B
Total Assets growth chart for AstraZeneca (AZN) from 2016 to 2025
Latest: +9.6%
Total Assets history table for AstraZeneca (AZN) from 1990 to 2025
| FY2025 | $114B | +9.6% | +$10B | ||
| FY2024 | $104B | +2.9% | +$2.92B | ||
| FY2023 | $101B | +4.8% | +$4.64B | ||
| FY2022 | $96.5B | -8.4% | -$8.88B | ||
| FY2021 | $105B | +57.9% | +$38.6B | ||
| FY2020 | $66.7B | +8.7% | +$5.35B | ||
| FY2019 | $61.4B | +1.2% | +$726M | ||
| FY2018 | $60.7B | -4.3% | -$2.7B | ||
| FY2017 | $63.4B | +1.3% | +$828M | ||
| FY2016 | $62.5B | +4.0% | +$2.4B | ||
| FY2015 | $60.1B | +2.6% | +$1.53B | ||
| FY2014 | $58.6B | +4.8% | +$2.7B | ||
| FY2013 | $55.9B | +4.4% | +$2.37B | ||
| FY2012 | $53.5B | +1.3% | +$704M | ||
| FY2011 | $52.8B | -5.9% | -$3.3B | ||
| FY2010 | $56.1B | +2.2% | +$1.21B | ||
| FY2009 | $54.9B | +17.0% | +$7.97B | ||
| FY2008 | $47B | -2.1% | -$1.01B | ||
| FY2007 | $48B | +60.2% | +$18B | ||
| FY2006 | $29.9B | +20.5% | +$5.09B | ||
| FY2005 | $24.8B | -3.2% | -$812M | ||
| FY2004 | $25.7B | +8.8% | +$2.08B | ||
| FY2003 | $23.6B | +9.3% | +$2B | ||
| FY2002 | $21.6B | -18.4% | -$4.87B | ||
| FY2001 | $26.4B | +43.4% | +$8B | ||
| FY2000 | $18.4B | -6.9% | -$1.36B | ||
| FY1999 | $19.8B | +120.6% | +$10.8B | ||
| FY1998 | $8.98B | +8.4% | +$698M | ||
| FY1997 | $8.28B | -3.3% | -$280M | ||
| FY1996 | $8.56B | +8.8% | +$693M | ||
| FY1995 | $7.87B | +7.5% | +$551M | ||
| FY1994 | $7.32B | -1.4% | -$106M | ||
| FY1993 | $7.42B | +20.0% | +$1.24B | ||
| FY1992 | $6.19B | -2.7% | -$174M | ||
| FY1991 | $6.36B | +4.3% | +$261M | ||
| FY1990 | $6.1B | — | — |
- FY2025$114B+9.6%
- FY2024$104B+2.9%
- FY2023$101B+4.8%
- FY2022$96.5B-8.4%
- FY2021$105B+57.9%
- FY2020$66.7B+8.7%
- FY2019$61.4B+1.2%
- FY2018$60.7B-4.3%
- FY2017$63.4B+1.3%
- FY2016$62.5B+4.0%
- FY2015$60.1B+2.6%
- FY2014$58.6B+4.8%
- FY2013$55.9B+4.4%
- FY2012$53.5B+1.3%
- FY2011$52.8B-5.9%
- FY2010$56.1B+2.2%
- FY2009$54.9B+17.0%
- FY2008$47B-2.1%
- FY2007$48B+60.2%
- FY2006$29.9B+20.5%
- FY2005$24.8B-3.2%
- FY2004$25.7B+8.8%
- FY2003$23.6B+9.3%
- FY2002$21.6B-18.4%
- FY2001$26.4B+43.4%
- FY2000$18.4B-6.9%
- FY1999$19.8B+120.6%
- FY1998$8.98B+8.4%
- FY1997$8.28B-3.3%
- FY1996$8.56B+8.8%
- FY1995$7.87B+7.5%
- FY1994$7.32B-1.4%
- FY1993$7.42B+20.0%
- FY1992$6.19B-2.7%
- FY1991$6.36B+4.3%
- FY1990$6.1B—
Total Assets values are taken from AstraZeneca's reported balance sheets (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Assets at AstraZeneca (AZN)
According to AstraZeneca's latest reported financial statements, the company's latest reported total assets is $116B. Total assets sum everything the company reports owning at the end of each reporting period — cash, receivables, inventory, property, plant, equipment, intangibles, and other holdings — as filed on the balance sheet. Compare with total liabilities and total equity for the capital-structure picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual total assets for AstraZeneca (AZN) came in at $114B – grew 9.6% year-over-year.
AstraZeneca total assets has grown for 3 consecutive years, with a +11.3% compound annual growth rate over 2020–2025 (5 years).
The highest annual total assets of $114B was reported in 2025. The lowest in the available history was $6.1B in 1990.
AstraZeneca Total Assets by Year
AstraZeneca Total Assets 2025: $114B
AstraZeneca posted total assets of $114B in 2025, grew 9.6% from 2024. This figure represents the highest annual value in the available history.
AstraZeneca Total Assets 2024: $104B
In 2024, AstraZeneca reported total assets of $104B, edged up 2.9% from 2023.
AstraZeneca Total Assets 2023: $101B
AstraZeneca total assets in 2023 was $101B, edged up 4.8% from 2022.
AstraZeneca Total Assets 2022: $96.5B
2022's total assets for AstraZeneca came in at $96.5B, declined 8.4% below 2021.
AstraZeneca Total Assets 2021: $105B
AstraZeneca total assets in 2021 was $105B.
See more financial history for AstraZeneca (AZN).
Sector peers by Total Assets
Healthcare peers of AstraZeneca (AZN), ranked by their latest total assets
| $310B | |
| $199B | |
| $137B | |
| $134B | |
| $112B | |
| $110B | |
| $90.6B | |
| $85.4B |
- $137B
- $134B
- $112B
- $90.6B
- $85.4B
Frequently asked questions
Test yourself on AZN
Market Cap — 10 rounds, every one of them AZN against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
AstraZeneca (AZN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks0.18% TTM
- Dividend Profile1.85% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History3 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.